The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component ...

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...

It’s a race against a single genetic marker — and musician turned biotech start-up CEO Casey McPherson says the stakes for ...

Professor Raj Mutharasan's lecture at the Roja Muthiah Research Library in Chennai was an in-depth exploration of one ...

A new blood test may help detect pancreatic cancer in its early stages with up to 97% accuracy, according to a recent study.

Muhle is one of many supporters of Legislative Bill 338 from State Sen. Dave “Woody” Wordekemper of Fremont, which seeks to ...

Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...

Kohntopp, who has led canine pathogen detection in Florida and California, is running her dogs through trials with Washington ...

The company aims to soon launch two tests to aid the treatment of dermatomycosis and is developing other tests for healthcare ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

The RetinalGeniX™ imaging system is designed to allow routine screenings to be conducted by general practitioners, optometric technicians, clinics, etc., giving highly specialized ophthalmologists and ...